India’s Serum Institute to get $150 million from Gates Foundation for COVID-19 vax

Serum Institute of India said on Friday it would receive $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make 100 million COVID-19 vaccine doses for India and other emerging economies as early as 2021.

The candidate vaccines, including those from AstraZeneca and Novavax, will be priced at $3 per dose and will be made available in 92 countries in GAVI’s COVAX Advance Market Commitment (AMC), the company said in a statement.

The Gates Foundation will provide the funds to GAVI, which will be used to support Serum Institute.

GAVI, backed by the Gates Foundation, is a public-private global health partnership with the goal of increasing access to immunization in poor countries.

It co-leads COVAX – a scheme designed to guarantee fast and equitable access globally to COVID-19 vaccines – along with the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI).

COVAX aims to deliver 2 billion doses of approved and effective COVID-19 vaccines by the end of 2021.

https://www.marketscreener.com/ASTRAZENECA-PLC-4000930/news/Serum-Institute-to-get-150-million-from-Gates-Foundation-for-COVID-19-vaccine-31077802/